Fenofibrate (ZINOF 200) is indicated as adjunctive therapy to diet for the treatment of hypertriglyceridemia (FREDRICKSON Types IV and V) and also for primary hypercholesterolemia or mixed dyslipidemia (FREDRICKSON Types IIa, IIb) who are at risk of pancreatitis and who do not respond adequately to dietary effort.